Hospital Pharmacy Regulation Report
|
|
- Loreen Rogers
- 6 years ago
- Views:
Transcription
1 Vol. 4 No. 6 June 2006 Hospital Pharmacy Regulation Report Decision rules INSIDE Turn to p. 7 to learn about a lesser-known but vital part of the JCAHO survey process that could have a serious effect on your pharmacy s and facility s accreditation decision. More FAQs on safety goals The JCAHO released a slew of frequently asked questions that clarify issues surrounding the medication-related National Patient Safety Goals. See p. 8 for more information. Insulin recommendations Insulin is a commonly used and dangerous drug. A new report lists recommendations on how to improve the safety and efficacy of insulin use. Learn more on p. 10. Pharmacy quality effort CMS has launched a new initiative that aims to improve pharmacy quality and develop new payment models. Turn to p. 11 for details. Proposed revisions unveiled for compounding USP 797 standards Changes focus on air quality, clarifications The U.S. Pharmacopeia (USP) has published proposed revisions to chapter 797, which outlines procedures and requirements for compounding sterile preparations. The USP seeks public comments about the revisions, which could take a year to finalize. The revisions are based on input received by the USP, but the standards-setting group hopes to re- Medication management (MM) standards continue to trouble hospitals, according to the JCAHO s hospital list of top standards compliance issues for ceive much more feedback, says Diane Cousins, RPh, the USP s vice president of patient safety. USP 797, titled Pharmaceutical Compounding Sterile Preparations, was originally released in January Two-thousand comments have been received since then, says Cousins. This is the first attempt to revise the standards. Go online to > p. 2 Med management standards high on most-cited JCAHO list for 2005 The list is rounded out by an environment of care (EC) standard, a leadership (LD) standard, a medical staff (MS) standard, and an infection control (IC) standard. Identifying unpackaged meds A new study found that 36% of pharmacists and physicians had difficulty identifying common medications removed from their original packaging. Read more on p. 12. FOR PERMISSION TO REPRODUCE PART OR ALL OF THIS NEWSLETTER FOR EXTERNAL DISTRIBUTION OR USE IN EDUCATIONAL PACKETS, PLEASE CONTACT THE COPYRIGHT CLEARANCE CENTER AT OR 978/ A list of the most frequently cited standards during surveys for each accreditation program is released annually by the JCAHO in its Perspectives publication, which all accredited organizations receive. The hospital list, released in May, includes 14 standards. Provision of care (PC) standards were also common on the list, and close behind as well as in the top position on the list are information management (IM) standards. The JCAHO also recently made available noncompliance data for its National Patient Safety Goals for full surveys conducted in Below are the standards and goals that made the lists, and the compliance issues or analysis, if available, based on information gathered during the JCAHO s Hospital Accreditation Essentials education seminar in Chicago in May. > p. 5
2 USP revisions < p. 1 to read the revisions. Comment period through August The public comment period runs through August 15, and Cousins says the USP will take its time sifting through everything before finalizing the revisions. It s possible that the changes could be unveiled in time for the next publication of the USP s Pharmacists Pharmacopeia in the summer of 2007, says Cousins. The final decisions about the revisions rest with the USP s 12-member Sterile Compounding Expert committee. The USP has posted two versions of the revised chapter on its Web site: one with the old language crossed out and new language added, and a numbered version with only the new language included. Users who submit electronic comments through the USP Web site can refer to changes by line number. We re hoping for a good number of comments, says Cousins. The USP would like to receive comments that provide alternate methods to accomplish a standard. They re free to suggest methods that might be appropriate, Cousins notes. suggested implementation times. any data or alternate practices. The USP s comment process has always been through the Pharmacopeial Forum, which was only open to paid subscribers. This time around, the USP is posting the proposed revisions online for free. The USP is also explaining the changes through the sale of a guidebook on its Web site and a series of six Webinars, which will feature speakers going through the main changes in the proposed revisions. JCAHO backs off 797 enforcement Shortly after the USP 797 was originally published, the JCAHO published a crosswalk in its Perspectives newsletter between USP 797 and its Medication Management standards (see Crosswalking USP 797 with JCAHO med standards on p. 4), and later in 2004 issued a timeline detailing dates by which hospitals should implement the various USP 797 standards. These moves led hospitals to grow concerned about how strictly JCAHO surveyors would check for compliance with USP 797. A look at proposed changes The proposed U.S. Pharmacopeia (USP) chapter 797 revisions include the following: A glossary of terms used in the chapter. A fourth microbial risk category of drug preparation Immediate Use compounded sterile preparations (CSP) which was created to exempt CSPs from the requirements described in the previous three categories: Low-risk level, medium-risk level, and high-risk level. A new section highlighting hazardous drugs as CSPs. It is consistent with the language found in publications from the National Institute for Occupational Safety and Health and the American Society of Health-System Pharmacists. A new section addressing issues related to compounding with radiopharmaceuticals. It refers to USP chapter 823 when compounding for positron emission tomography. Requirements for primary and secondary engineering controls in cleanrooms, biological safety cabinets, and compounding aseptic isolators. Revisions to the section on environmental monitoring that refer to USP chapter 1116 on microbial monitoring of cleanrooms, anterooms, and ISO Class 5 engineering controls. A section on personnel cleansing and garbing that provides information about hand hygiene and personnel garbing requirements. Revised sterility storage times and stability beyond-use dates. Page HCPro, Inc.
3 The JCAHO s recommended deadlines called for hospitals to determine how well they conformed to USP 797, and what renovation plans would be needed by January 1, As of July 1, 2005, hospitals were to have instituted any interim measures to offset deficiencies in USP 797, according to the deadline. In the April Perspectives, the JCAHO clarified its stance and put the onus of USP 797 compliance back on hospitals. An accredited organization determines how it best can comply with the requirements specified in USP 797, and what time frames for compliance are reasonable, according to the clarification. The Joint Commission will not survey for compliance with the details of USP 797. How exacting the organization complies with the USP 797 guidelines and the suggested time frames for compliance are based on organizational decisions. The article conceded that USP 797 is a valuable set of guidelines that describe a best practice for establishing safe processes in compounding sterile medications, which will help hospitals comply with JCAHO standard MM.8.10.The standard requires organizations to evaluate literature for new technologies and successful practices relevant to improving their medication management systems. Although organizations will not be surveyed against the details of USP 797 guidelines, organizations that do not, at a minimum, review their processes for preparing sterile medications in light of USP 797, will be found noncompliant with standard MM.8.10, according to the Perspectives clarification. Few regulatory groups enforce USP 797, and the JCAHO s decision to back off on enforcement meant that no accreditors claim to do so, according to an article in the June 1 American Journal of Health-System Pharmacy. Nine states in March 2005 told the National Association of Boards of Pharmacy that they require pharmacies to comply with USP 797, and six other state boards of pharmacy taking part in the survey said they were considering enforcing the standards. Early reaction is mixed One organization that had raised concerns about the JCAHO s initial position on USP 797 is the American Society of Healthcare Engineers (ASHE), which called last year for the JCAHO to reconsider. The accreditor s latest statement on the subject was more to ASHE s liking, says Dale Woodin, ASHE s deputy director of advocacy. The clarification that came out in Perspectives [in April] was encouraging, he notes. A lot of this was confusion. We want to see what happens. ASHE felt that the JCAHO had amplified its standards to include another standard, Woodin says. It came off as very heavy-handed before, he adds. It was both prescriptive and not clear. As for the USP s proposed revisions to Chapter 797, Woodin says ASHE is still reviewing them but has initial problems with some of the changes. The air quality requirements they re calling for are substantial and concerning. Changes are good, but you have to have a reason for [them]. ASHE has asked the USP to provide evidence backing up its proposed changes. At first blush, it seems onerous, Woodin says. We need to see evidence that going to a higher level of air quality is necessary. Such changes would prove expensive, and in some cases, be especially difficult for hospitals that installed new cleanrooms after the first version of USP 797 came out in 2004, adds Woodin. We re working within our membership to determine what it would take to accomplish these things, he says. How much would it cost? Revisions make standards more clear The proposed revisions clear up much of the language in USP 797, says Steven MacArthur, consultant with The Greeley Company in Marblehead, MA, which is owned by HCPro, Inc., the publisher of this newsletter. In looking at the proposed changes, my sense is that a lot of the language is what I would term clarification and, unlike the Joint Commission s usual at- > p HCPro, Inc. Page 3
4 USP revisions < p. 3 tempts at clarification, the revised version does appear to actually make the specific components easier to understand, he says. Which is not to imply that somehow the original was not particularly clear. One example of clarification is the USP s changing of the term sanitizing to disinfecting throughout the revised document, MacArthur notes. Another terminology change would drop (in certain cases) pharmacy as a place where compounded sterile preparations (CSP) are prepared and replace it with compounding facility, which could refer to situations in which compounding takes place in locations other than the pharmacy, he adds. The changes are also indicative of challenges that folks have encountered in the real world and found themselves in a deficient practice with no way to get to compliance, MacArthur says. For example, the inclusion of Immediate Use CSPs as a preparation category. Sometimes, in an emergency, all the sterile technique in the world can get in the way of making sure that the patient receives the materials in a timely fashion. We don t want to endanger someone in one direction while in the process of saving his or her life. It can be a delicate balance. The revised chapter provides more guidance on how to meet environmental requirements, he says. We re still going to have to deal with the ISO classes for environmental air quality, still going to have to do periodic monitoring, depending on the risk level of the compounding going on, etc., notes MacArthur. Folks that are engaged in high-risk compounding are going to have to do a lot of work to make sure they ve got an environment that supports that activity. Editor s note: To submit a comment about the USP chapter797 proposed revisions, visit USPNF/pf/797comments.html. Crosswalking USP 797 with JCAHO med standards The U.S. Pharmacopeia chapter 797 Written compounding procedures including quality control checks for proper ingredients and visual inspection of final product Sterilizing nonsterile products Testing product for sterility, potency, etc. Expiration labeling according to risk level Medication packaging and transportation Redispensing compounded sterile preparations Watching patients and reporting adverse events JCAHO medication management (MM) standards MM.4.20 (safely preparing medications) MM.4.20 (safely preparing medications) MM.4.20 (safely preparing medications) MM.4.30 (labeling medications) MM.4.40 (safely dispensing medications) MM.4.80 (managing returned medications) MM.5.10 (reporting), MM.6.10 (monitoring) Source: Adapted from the April 2004 Joint Commission Perspectives. Page HCPro, Inc.
5 MM standards < p. 1 National Patient Safety Goals The percentages below relate to the number of hospitals not in compliance with the goals (identified by their numbers in 2005). Comparison data for 2004 and 2003 are noted, where applicable: #1a (two identifiers scored at PC.5.10 EP4), 3.9% (compared to 4.1% in 2004 and 3.8% in 2003). #1b (time-out), 17.1% (8% in 2004, 8.9% in 2003). The large percentage increase can be attributed to this goal expanding beyond operating rooms. #2a (verbal orders scored at IM.6.50 EP4), 11.6% (8.2% in 2004, 7.4% in 2003). JCAHO surveyors are finding that policies don t always match practice. For example, some facilities require documentation of a read-back (although it s not required by the JCAHO). If your policy requires you to document read-backs, and surveyors observe them not being documented, you can earn a requirement for improvement (RFI) for not following your own policy for documentation. However, to comply with this goal, the JCAHO says it s enough to observe the behavior. #2b (abbreviations scored at IM.3.10 EP2), 39.5% (24.8% in 2004, 23.5% in 2003). If your facility is still choosing to add additional abbreviations to the JCAHO s official list (no longer required), and surveyors observe those additional prohibited abbreviations being used, you can earn an RFI because you wouldn t be following your own policy. #2c (timeliness of reporting critical test results), 7.6%. #3a (concentrated electrolytes scored at MM.2.20 EP9), 1.3% (1.9% in 2004, 3% in 2003). #3b (limit concentrations scored at MM.2.20 EP8), 1.5% (0.9% in 2004 and 0.6% in 2003). #3c (look-alike/sound-alike drugs), 1.9%. #4a (preoperative verification), 5.5% (5.4% in 2004 and 1.5% in 2003). #4b (surgical site marking), 3.8% (4.6% in 2004 and 6.2% in 2003). #5a (free-flow protection), 0.1% (0.1% in 2004 and 1.4% in 2003). #7a (hand-hygiene scored at IC.4.10 EP2), 3.6% (1.2% in 2004). Risks associated with animals brought into facilities tripped up some organizations here. The JCAHO recommends looking to home care organizations as a good source of information about how to meet this goal because this is a common issue for those facilities. #7b (healthcare associated infections and rootcause analysis), 0% (0.1% in 2004). #8a (medication reconciliation list), 0%. #8b (medication reconciliation), 0.3%. #9a (patient falls), 3%. No noncompliance data are yet available for the 2006 goals, although the JCAHO has extensively updated its frequently asked questions (FAQ) for them, available at FAQs are the official documents of JCAHO goals interpretation and are used by surveyors. They represent common questions that the field sends to the JCAHO s standards interpretation group (see JCAHO releases National Patient Safety Goals FAQs on p. 8 for more information). If a goal and a standard have the same requirements, and you are found out of compliance, you can only be scored in one place so you are safe from double jeopardy scoring, as the JCAHO refers to it. Standards The percentages below relate to the number of hospitals not in compliance with the following standards in the Comprehensive Accreditation Manual for Hospitals (CAMH ). Comparison data for 2004 follow, if applicable. Consult the CAMH for the exact wording of each standard and all of its requirements: IM.3.10 (information management processes), 41% (compared to 27% in 2004). Using prohibited abbreviations is the biggest barrier to compliance, according to the JCAHO (see goal #2a at left). MM.2.20 (medication storage), 37% (20% in 2004). Surveyors often find open, unattended anesthesia carts. Also, the JCAHO recommends that your facility have a strict policy for denying access to > p HCPro, Inc. Page 5
6 MM standards < p. 5 medication dispensing machines (i.e., Pyxis) immediately after employees are terminated. PC (sedation/anesthesia), 30% (18% in 2004, 9.1% in 2003). Surveyors expect informed consent for procedures and a preanesthesia assessment. Although the JCAHO doesn t tell organizations how to document this, surveyors do look at records. And although this isn t as tough an issue in units such as the operating room, it is in units such as radiology. The JCAHO says the forms used in each unit don t necessarily have to be uniform, but they should be equal or comparable and the anesthesia department should be involved in their development. EC.5.20 (Life Safety Code [LSC]), 21%. The addition of a LSC surveyor on survey teams for hospitals greater than 200 beds lead to an increased number of findings under this standard. MM.3.20 (written orders), 20% (17% in 2004). One way to help meet this standard is to eliminate range orders. If you use them, the JCAHO recommends attaching definitions or pain scales to eliminate the need for a nurse to employ judgment. IM.6.50 (verbal order transcription), 15% (10% in 2004). To help meet this standard, the JCAHO recommends you have a policy that doesn t allow verbal orders except in emergency situations (see goal #2a on p. 5). PC.8.10 (pain assessment), 15% (13% in 2004). Hospitals aren t having trouble with assessing pain so much as they having a problem with reassessing pain. If your policy says you ll reassess pain in two hours, you must follow your policy and do it, or you may receive an RFI for not complying with your policy. IM.6.10 (medical records complete), 15% (12% in 2004). There are several areas in which surveyors find hospitals not meeting this standard. One is authentication you are required to have a date next to every signature in the medical record. Another problem area is medical record delinquency rate data the JCAHO says not to do these in percentages but in numbers. Surveyors will want to look at your average monthly discharges and delinquency rates over four quarters. PC (initial assessment time frames), 13%. Surveyors often discover missing nutritional screenings. LD.3.90 (leaders develop/implement policies), 13%. Surveyors find that leaders fail to hold people accountable. EC.1.10 (safety risk management), 11%. Meeting this standard requires the organization to have completed a comprehensive, proactive risk assessment, and surveyors will ask questions about it. Leaders should also be able to speak to how the organization responds to the JCAHO s Sentinel Event Alerts. MM.4.10 (medication order review), 11% (13% in 2004). If a pharmacy is located in the hospital, all medications must be reviewed by the pharmacy, except in emergency situations or in the event that a licensed independent practitioner can review them. Also troublesome for some organizations are the rules for oral contrast media, which the JCAHO considers a drug and must be reviewed by a pharmacist. MS.4.20 (clinical privileges), 10% (9% in 2004, 6% in 2003). Surveyors are finding caregivers providing care outside of the settings in which they have privileges. Also, surveyors are finding expired privileges (those extended beyond two years). IC.4.10 (goal achievement), 10% (12% in 2004). Surveyors are finding that organizations are having problems meeting the requirements for reducing risk associated with equipment and procedures, (e.g., storage, cleaning, sterilization, and disposal), appropriate reuse, and protective equipment use (see goal #7a on p. 5). Questions? Comments? Ideas? Contact Senior Managing Editor Jay Kumar Telephone: 781/ , Ext jkumar@hcpro.com Page HCPro, Inc.
7 Decision rules play key role in JCAHO surveys Expert: Make sure that staff are well-versed in these rules An underpublicized set of rules can have a major effect on JCAHO accreditation decisions if hospital staff are unaware of them. Called decision rules, these guidelines are printed in plain sight in the Comprehensive Accreditation Manual for Hospitals (CAMH), but they are often overlooked because of the emphasis on standards and National Patient Safety Goals, says Kurt Patton, MS, RPh, former executive director of accreditation for the JCAHO and current principal of Patton Healthcare Consulting of Glendale, AZ. I ve been advising people to understand the decision rules because of the impact they can have on overall decisions, he adds. A lot of people rely upon the JCAHO s small, hardbound manual, but that doesn t have the section on decision rules, says Patton, a former hospital pharmacist. The rules are included in the CAMH, but people never bother to read them, he says. JCAHO surveyors make accreditation decisions by applying decision rules to the scored standards. Decision rules determine an accreditation finding that appropriately represents a hospital s overall performance as measured by evidence of compliance with the applicable standards, according to the CAMH. In addition, since 2001, the JCAHO has put in place weighted decision rules to limit the effect that small or secondary components of a complex organization may have on the overall accreditation decision. However, the JCAHO recently revised the rules to apply equally throughout an organization if a component s decision involved threats to patient safety, instances in which inaccurate information was provided to the JCAHO, or a violation of other accreditation participation requirements. In these instances, when a secondary component receives a finding of conditional accreditation or preliminary denial of accreditation, that accreditation decision would apply equally to the component and the overall organization. The JCAHO also made a similar revision so that the effect of an in-house pharmacy s performance would apply equally to a hospital s accreditation. Educate staff about key rules Department managers such as pharmacy directors should point their staff to the CAMH and make sure that they read and understand the major decision rules, Patton recommends. Identify the half-dozen heavy hitters and train staff on those, he says. The rules are featured on pp of the Accreditation Policies and Procedures section of the manual. [The JCAHO] identifies a handful of standards that people need to really know are locked down tight, Patton says. The increased emphasis on decision rules can be attributed to enhanced surveyor training focusing in part on falsification and improved laptop technology that alerts surveyors to when the decision rules are triggered, says Patton. The decision rules for preliminary denial of accreditation include the following: An immediate patient safety or health threat exists within the organization. A practitioner who does not possess a license, registration, or certification has been providing healthcare services that would require such licensure, placing the organization s patients at risk. The JCAHO believes that the organization submitted falsified documents or misrepresented information to achieve or retain its accreditation. This could include discovering after surveyors arrive that certain paperwork wasn t done, then completing it to make it appear as though the paperwork had been done before the survey began, Patton says. A better idea is to sequester that paperwork to prevent any appearance of falsification. The organization doesn t possess a license, certificate, or permit required to provide the services for which it seeks accreditation HCPro, Inc. Page 7
8 JCAHO releases National Patient Safety Goals FAQs The JCAHO in February published 29 new frequently asked questions (FAQ) about the medication-related 2006 National Patient Safety Goals (NPSG), with many of the clarifications being about the troublesome medication reconciliation goal. The commission develops FAQs in response to multiple requests for clarifications of standards, elements of performance, or NPSGs and requirements. In addition to the new FAQs, the JCAHO revised and reviewed many others already posted online. Medication safety The JCAHO responded to questions about NPSG #3 on medication safety, specifically requirements #3b (requiring hospitals to standardize and limit drug concentrations), #3c (look-alike/sound-alike drugs), and #3d (medication labeling). The commission elaborated on its position on the Broselow Tape, a tool used in pediatric emergencies to determine weight-based drug doses. The FAQ notes that some surveyors have mistakenly told hospitals that they were not in compliance with requirement #3b if they continued to keep Broselow Tapes in their crash carts, but this is not accurate. The JCAHO takes issue with the Broselow Tape because it allows users to mix customized concentrations instead of standardized concentrations, which goes against the goal that all hospitals move to standardized drug concentrations by The accreditor acknowledges the utility of the Broselow Tape in the emergency care of children; it s also used to estimate a child s weight and select the correct size of emergency or resuscitation equipment. As a result, hospitals may continue to use the tool for functions other than drug concentrations. With look-alike/sound-alike medications, the JCAHO provides lists of such meds for hospitals to identify 10 pairs that they use. If a hospital cannot find 10 pairs from the JCAHO s lists, it should consult other lists of look-alike/sound-alike drugs on the Web sites of the Institute for Safe Medication Practices ( and the U.S. Pharmacopeia ( Another question asks whether different doses of the same medication should be treated as look-alike/ sound-alike drugs. This is not covered under requirement #3c, which aims to eliminate confusion between different drugs, not different concentrations. Labeling Asked if requirement #3d applies only in the operating room, the JCAHO noted that it also applies to preparation areas, preop holding, and postanesthesia care units. In addition, the requirement applies to medications used by anesthesia providers, and all procedural areas that use medications or solutions including radiology and other imaging services, endoscopy units, dental services, and patient care units in which staff perform bedside procedures. Another new FAQ details the information that must be included on the labels of medications and solutions in context of requirement #3d. Consistent with standard MM.4.30, Elements of Performance 3 and 4, labels must include the following: Drug name, strength, and amount (if not obvious from the container). Expiration date when not used within 24 hours. Expiration time if less than 24 hours. This applies to a select few drugs. Date prepared and the diluent for all compounded intravenous admixtures. In most cases of meds and solutions in the procedural setting, only the drug name and concentration will be needed on the label. Medication reconciliation NPSG #8 (accurately and completely reconcile medications across the continuum of care) has continued to confound hospitals. Requirement #8a calls on hospitals to implement a process for obtaining and documenting a complete list of a patient s current meds upon admission to the facility. The patient should be involved in the process, which should include a com- Page HCPro, Inc.
9 parison of the meds that the facility provides to those on the list. Requirement #8b adds that a complete list of a patient s medications must be communicated to the next provider of service when a patient is referred or transferred to another setting, service, practitioner, or care level either in or outside of the organization. Asked about the required time frame for completing a medication list after a patient enters the organization, the JCAHO said hospitals ideally should have a list ready before ordering any new meds. If unable to do so, a hospital must decide whether to wait until the medication list is available or order the meds and perform the reconciliation as soon as the list is available. Such a decision must be made based on the relative risk to the patient. For inpatients, the list should be done within 24 hours, the same time frame required for other assessments of inpatients. The commission recommends that inpatient facilities consider establishing a shorter time frame for gathering information about high-risk medications the patient may be taking (e.g., insulin, opiates, or anticoagulants). In other care settings, the organization should define the time frame requirements for completing the list of meds. If a facility is unable to obtain a complete list of patient meds, the JCAHO will still consider it in compliance with the requirements if a process is in place and is implemented for each patient. When a patient is discharged, the facility should develop a complete list of meds that the patient should take following discharge. The list should be reconciled against both the current inpatient list and the home medication list. The discharge list should include the meds prescribed at the time of discharge, as well as any other meds the patient will be taking, such as over-the-counter drugs and vitamins. To access the complete list of FAQs, visit com/zekg2. A look at the new JCAHO FAQs The following is a sampling of the new JCAHO frequently asked questions regarding medication-related National Patient Safety Goals (NPSG) posted on the accreditor s Web site: What is the JCAHO s position with respect to the Broselow Tape, the Rule of Six, and the requirement under NPSG #3 for limiting and standardizing drug concentrations in healthcare organizations? Does NPSG #3b require that total parenteral nutrition solutions be standardized in their component concentrations, including electrolytes? Do we need to treat different dosages of the same medication as look-alike/sound-alike drugs? Does NPSG #3d apply only in the operating room? Are there any exceptions to the labeling requirement? When labeling medications and solutions in the context of NPSG #3d, what information must be on the label? We have discovered that presterilized, prelabeled syringes are now commercially available. Is this acceptable? When requirement #3d was first announced, the implementation expectations said the initials of the person preparing the medication or solution and the date of preparation needed to be on the label. Are those items still required? Is two-person verification of the label still required? Is it acceptable to label a syringe by taping the medication vial to the syringe? What solutions are best for labeling medication cups and basins on the sterile field? What does the JCAHO expect for labeling contrast media that are loaded into power injectors? 2006 HCPro, Inc. Page 9
10 Panel releases recommendations for safe insulin use A report released in early 2006 by the American Society of Health-System Pharmacists (ASHP) offers a series of recommendations designed to improve the safety and efficacy of hospital insulin use. Preventable patient injuries associated with errors involving insulin use continue to be a problem in many hospitals, the report notes. The guidelines in the report are intended to meet and exceed current JCAHO standards and clinical recommendations from ASHP, the American Diabetes Association, and other professional groups. Twelve percent of patients discharged from hospitals have been diagnosed with diabetes, and up to 25% of all hospitalized patients meet the criteria for a diabetes diagnosis, according to the report. Medications and stress can cause many nondiabetic patients to develop hyperglycemia while hospitalized. Insulin is used to treat both of these groups of patients to manage hyperglycemia. According to the report, types of insulin-use errors include the following: Administration of a wrong dose Administration to the wrong patient Use of the wrong insulin type Administration via the wrong route Wrong timing of doses Omission of doses Failure to properly adjust insulin therapy Improper monitoring, timing, and assessment of blood glucose results Factors that contribute to insulin-use errors include the use of abbreviations legibility problems calculation errors measurement errors poor timing of doses look-alike/sound-alike errors decimal point errors pump-setting errors lack of drug therapy knowledge inadequate access to and interpretation of patient information miscommunication Recommendations The report offers the following high-level recommendations necessary for organizations to make significant changes in the safety and efficacy of insulin therapy: The organization should designate a high-level project leader/sponsor with overall responsibility for program success. The insulin therapy multidisciplinary group should coordinate and lead development of institutional policies and procedures for insulin practices. Institutional policies should incorporate safe medication practices in general, as well as insulin-specific practices. Policies should establish evidence-based target standards for glycemic control for patients in the hospital. Policies should require the ordering of all components of insulin therapy in a defined format, preferably using mandatory, preprinted, guideline-based order sets for most patients who are prescribed insulin. Order-process design should incorporate medication-safety principles and evidence-based blood glucose control standards. Insulin orders should prompt and facilitate order transcription, pharmacist and nurse order review, pharmacy computer order entry, and nursing workflow. Insulin orders should include or refer to defined standards for laboratory and clinical insulin therapy monitoring practices. Insulin administration records, glucose monitoring results, and carbohydrate intake should be effectively displayed to allow caregivers to accurately and efficiently assess data. Institutional policies should promote and provide for the ongoing involvement of patients and families in care processes. To read the report, visit Safe_Use_of_Insulin.pdf. Page HCPro, Inc.
11 CMS initiative focuses on improved pharmacy quality A new Centers for Medicare & Medicaid Services (CMS) effort to measure and compare the quality of pharmacy services hopes to eventually provide incentives for improved patient care. The Pharmacy Quality Alliance (PQA) launched in April as a joint project of CMS and other key group such as America s Health Insurance Plans, the National Community Pharmacists Association, and the National Association of Chain Drug Stores. The PQA follows similar CMS initiatives such as the Hospital Quality Initiative and the Ambulatory Care Quality Alliance. CMS Administrator Mark McClellan said during an April 24 conference call that the PQA could lead to increased payments to pharmacies, according to the American Journal of Health-System Pharmacy. The alliance will focus on developing strategies for defining and measuring pharmacy performance, as well as testing new pharmacy payment models, he said. The PQA in early May announced the formation of a steering committee representing various stakeholders, including McClellan; Carolyn Clancy, MD, director of the Agency for Healthcare Research and Quality; Judith Cahill, executive director of the Academy of Managed Care Pharmacy; and other representatives from pharmacy and consumer groups. The mission of the PQA is to improve healthcare quality and patient safety through a collaborative process in which the key stakeholders agree on a strategy for measuring performance at the pharmacy and pharmacist levels; collecting data in the least burdensome way; and reporting meaningful information to consumers, pharmacists, employers, payers, and other healthcare decision-makers to help make informed choices, improve outcomes, and stimulate the development of new payment models, according to a PQA release. The PQA has established two work groups, one focused on measurement and the other on reporting. Membership in the PQA and participation in its work groups is open to all interested stakeholders. The entire membership of the PQA will meet twice per year to discuss and reach consensus on the work groups activities and recommendations. The PQA named Laura Cranston as its executive director. Cranston is president of Cranston & Associates, a Virginia-based consulting firm. Previously, she served as the executive director for the Institute for the Advancement of Community Pharmacy. For more information about the PQA, visit HPRR Subscriber Services Coupon Start my subscription to HPRR immediately. Options: No. of issues Cost Shipping Total Print 12 issues $299 (HPRRP) $24.00 Electronic 12 issues $299 (HPRRE) N/A Print & Electronic 12 issues of each $374 (HPRRPE) $24.00 Order online at Be sure to enter source code N0001 at checkout! Sales tax (see tax information below)* Grand total For discount bulk rates, call toll-free at 888/ *Tax Information Please include applicable sales tax. Electronic subscriptions are exempt. States that tax products and shipping and handling: CA, CT, FL, GA, IL, IN, KY, MA, MD, MI, NC, NJ, NY, OH, OK, PA, RI, SC, TN, TX, VA, VT, WA, WI. States that tax products only: AZ. Please include $27.00 for shipping to AK, HI, or PR. Your source code: N0001 Name Title Organization Address City State ZIP Phone address (Required for electronic subscriptions) Fax Payment enclosed. Please bill me. Please bill my organization using PO # Charge my: AmEx MasterCard VISA Signature (Required for authorization) Card # (Your credit card bill will reflect a charge to HCPro, the publisher of HPRR.) Expires Mail to: HCPro, P.O. Box 1168, Marblehead, MA Tel: 800/ Fax: 800/ customerservice@hcpro.com Web: HCPro, Inc. Page 11
12 Study: Pharmacists, docs struggle to ID unpackaged meds Pharmacists and physicians were unable to identify three common medications removed from their original containers more than one-third of the time, according to a new study. Current FDA regulations allow drug companies to develop and assign identification (ID) codes to their medications, meaning that there is no standard ID system for meds. As a result, if 10 companies made 10 acetaminophen products, each could have a different code. Removing them from their original packaging could create a safety problem, according to a release from the American Society of Health-System Pharmacists (ASHP) Foundation, which cofunded the study with the U.S. Pharmacopeia. Healthcare professionals often must identify an unpackaged medication. For example, an elderly patient may arrive in the emergency department with meds kept in a pill organizer, but may not be able to remember the names of all of the medications that he or she takes. The pharmacist or physician must consult a clinical database containing imprint identification information to identify each pill. This could delay treatment and yield incomplete information because no imprint ID database contains every code used, according to the ASHP Foundation release. This can also be a problem with patients who have overdosed or who refill a prescription at a community pharmacy and want to know why the new pills look different from the old ones, the foundation wrote. Researchers randomly chose 50 pharmacists and 50 physicians from two urban teaching hospitals to test their ability to identify three medications: a brandname tablet, generic tablet, and nonprescription generic tablet. Only 24 pharmacists (36%) and 18 physicians (48%) were able to identify all three medications. Ten physicians (20%) and five pharmacists (10%) could not correctly identify any of the tablets. The study was published in the May 1 American Journal of Health-System Pharmacy. Visit org/cgi/content/abstract/63/9/838 to read an abstract of the study. Hospital Pharmacy Regulation Report Editorial Advisory Board David Benjamin, PhD Clinical Pharmacologist/Toxicologist Chestnut Hill, MA Diane Cousins, RPh Vice president, Center for the Advancement of Patient Safety U.S. Pharmacopeia Rockville, MD Michael Hoying, RPh, MS Pharmacy Director Fairview and Lutheran Hospitals Cleveland, OH Kurt Patton, MS, RPh Principal Patton Healthcare Consulting Glendale, AZ James O Donnell, PharmD, MS Associate Professor of Pharmacy Rush University Medical Center Chicago, IL William Sarraille, Esq. Sidley Austin Brown & Wood, LLP Washington, DC Donna Soflin, PharmD Director of Pharmacy Tri-County Hospital Lexington, NE Douglas Wong, PharmD Pharmacy Healthcare Solutions AmerisourceBergen Corporation Fort Washington, PA We want to hear from you... For news and story ideas: Contact Senior Managing Editor Jay Kumar Phone: 781/ , Ext Mail: 200 Hoods Lane, Marblehead, MA jkumar@hcpro.com Fax: 781/ Group Publisher: John Novack Online resources: Web site: Access to past issues: Subscriber services and back issues: For new subscriptions, renewals, changes of address, back issues, billing questions, or permission to reproduce any part of Hospital Pharmacy Regulation Report, please call customer service at 800/ Hospital Pharmacy Regulation Report is published monthly by HCPro, Inc., 200 Hoods Lane, P.O. Box 1168, Marblehead, MA Subscription rate: $299/year or $538/two years Copyright 2006 HCPro, Inc. All rights reserved. Printed in the USA. Except where specifically encouraged, no part of this publication may be reproduced, in any form or by any means, without prior written consent of HCPro, Inc., or the Copyright Clearance Center at 978/ Please notify us immediately if you have received an unauthorized copy. For editorial comments or questions, call 781/ or fax 781/ For renewal or subscription information, call customer service at 800/ , fax 800/ , or customerservice@hcpro.com. Occasionally, we make our subscriber list available to selected companies/vendors. If you do not wish to be included on this mailing list, please write to the Marketing Department at the address above. Opinions expressed are not necessarily those of HPRR. Mention of products and services does not constitute endorsement. Advice given is general, and readers should consult professional counsel for specific legal, ethical, or clinical questions. Page HCPro, Inc.
The CMS Survey Guide Jeffrey T. Coleman
The CMS Survey Guide Jeffrey Jeffrey T. T. Coleman Coleman Contents About the Author......................................................... v Introduction............................................................
More informationThe CMS. Survey. Coordinator s. Handbook. Jeffrey T. Coleman
The CMS Survey Coordinator s Handbook Jeffrey T. Coleman Table of contents About the author... iv Introduction... v Chapter 1: Know your surveyor... 1 Chapter 2: Know your survey... 5 Chapter 3: Know the
More informationKurt A. Patton, MS, RPh with a foreword by Thanasekaran Sinnathamby, MD Handoff Communication Handoff Handoff Communication, Global Edition:
Handoff Contents About the author......................................... v Foreword............................................... vii Introduction............................................. xii Chapter
More informationDefensive Documentation for Long-Term Care
Defensive Documentation for Long-Term Care Strategies for creating a more lawsuit-proof resident record Tra Beicher RNC, ARM, HRM, CWS Contents About the author............................................
More informationEvidence-Based Falls Prevention
A Study Guide for Nurses Second Edition Carole Eldridge, DNP, RN, CNAA-BC Patient falls remain the largest single category of reported incidents in hospitals, making falls prevention a vital National Patient
More informationContents. About the Author... v. Introduction... vii. Chapter One: ASC Governance/Organizational Structure... 1
Contents About the Author............................................................. v Introduction................................................................ vii Chapter One: ASC Governance/Organizational
More informationThe Joint Commission Medication Management Update for 2010
Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program
More informationHospital Pharmacy Regulation Report
Vol. 3 No. 3 March 2005 Hospital Pharmacy Regulation Report INSIDE DEA wants feedback The DEA seeks comments about pain management guidelines. Find out how to submit them on p. 3. Review ED orders The
More informationTable of Contents. Introduction: Letter to managers... viii. How to use this book... x. Chapter 1: Performance improvement as a management tool...
Table of Contents Introduction: Letter to managers......................... viii How to use this book.................................. x Chapter 1: Performance improvement as a management tool..................................
More informationHospital Pharmacy Regulation Report
Vol. 1 No. 5 July 2003 Hospital Pharmacy Regulation Report INSIDE The JCAHO releases new 2004 medication management standards Medication management 3 Consider this information from your peers on their
More informationUnderstanding USP 797
Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP
More informationGayle Bielanski, RN, BS, CPHQ, CSHA CORE. Practical Guide to MEASURES IMPROVEMENT
Gayle Bielanski, RN, BS, CPHQ, CSHA Practical Guide to CORE MEASURES IMPROVEMENT Practical Guide to CORE MEASURES Improvement Gayle Bielanski, RN, BS, CPHQ, CSHA Practical Guide to Core Measures Improvement
More informationHospital Pharmacy Regulation Report
Vol. 4 No. 9 September 2006 Hospital Pharmacy Regulation Report INSIDE IOM recommendations See p. 5 for a look at the recommendations made by the Institute of Medicine s report on preventing medication
More informationJCAHO Med Management
Hospital Pharmacy Volume 41, Number 9, pp 888 892 2006 Wolters Kluwer Health, Inc. JCAHO Med Management Meeting the Standards for Emergency Medications and Labeling Patricia C. Kienle, MPA, FASHP* This
More informationA Game Plan to Surviving a Joint Commission Survey. May Adra, BS Pharm, PharmD, BCPS
A Game Plan to Surviving a Joint Commission Survey May Adra, BS Pharm, PharmD, BCPS Objectives Describe key components of a Joint Commission accreditation visit Identify changes to medication management
More informationCAMH February 2005 Update HIGHLIGHTS
CAMH February 2005 Update HIGHLIGHTS STANDARD UP 1. How to Use Manual Multiple changes to scoring, category changes and Measure of Success (MOS) designation removed 2. Accreditation Policies & Procedures
More informationThe Joint Commission Medication Management Update for 2010
The Joint Commission Medication Management Update for 2010 U.S. Army Manager, Army Patient Safety Program U.S. Army Medical Command Fort Sam Houston, TX CPE Information and Professional Resources & Business
More informationOverview. Diane Cousins, R.Ph U.S. Pharmacopeia. 1 Pharmacy Labeling with Color
As more medications are approved and become available to Americans, the opportunity for potentially dangerous or even deadly errors due to drug mix-ups from look alike or sound alike names becomes increasingly
More informationDealing with difficult families
November 2010 Vol. 8, No. 11 CNAs will sometimes deal directly with family members, so they should always be prepared for that interaction. Families feel the stress and strain of admitting a loved one
More informationADLs. Program Prep. Tips and tools for CNA training. About your CNA training advisor. Questionnaire answer key. Program time. Learning objectives
August 2009 Vol. 7, o. 8 ALs Most of us take for granted the simple activities of daily living (AL), such as getting dressed, eating, and moving from place to place. But for many nursing home residents,
More informationThe Leader in Guidance for the Health Information Management Profession. Patient Safety Monitor Journal
The Leader in Guidance for the Health Information Management Profession Patient Safety Monitor Journal Volume 18 Issue No. 1 January 2017 USP : Protecting healthcare workers from hazardous drugs According
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationMedication Storage and Security: The #1 Non- Complaint Medication Management Standard
Learning Objectives and Security: The #1 Non- Complaint Medication Management Standard d Manager, Army Patient Safety Program U.S. Army Medical Command Fort Sam Houston, TX Describe the importance of maintaining
More informationCHAPTER 8 Hospital Accreditation
CHAPTER 8 Hospital Accreditation 8.1 HOSPITAL PHARMACY OVERVIEW Consultant of Record for the permit is responsible for all medication use in the facility. Director of Pharmacy usual hospital title for
More informationHospital Pharmacy Regulation Report
Vol. 3 No. 10 October 2005 Hospital Pharmacy Regulation Report INSIDE Top five problematic standards Check out the five most-cited standards so far in 2005 on p. 5. Fentanyl patch safety Get expert tips
More informationHospital Pharmacy Regulation Report
Vol. 2 No. 6 June 2004 Hospital Pharmacy Regulation Report INSIDE Case study A patient at one hospital suffered a stroke after a communication breakdown. Read about the dangerous implications of blanket
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationThe ACHC-PCAB Pharmacy Accreditation Program
CPE CREDIT 1.0 Current & Practical Compounding Information for the Pharmacist VOLUME 19 NUMBER 1 Grant funding provided by Perrigo Pharmaceuticals Goal: To provide information on the importance and procedures
More informationTeamwork. Program Prep. Your shortcut to compliant documentation. What is a team? Quiz answer key
November 2012 Vol. 10, No. 11 Teamwork Teamwork is a vital component of a CNA s job. A CNA must consistently work with and exchange information with residents, fellow CNAs, nurses, and supervisors in order
More information2018 Pharmacy Education Series
2018 Pharmacy Education Series February 21, 2018 2018 Joint Commission Update Featured Speakers: Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation & Medication Safety Cardinal Health Innovative
More informationPractice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey
Practice Advancement Initiative (PAI) Using the ASHP PAI Ambulatory Care Self-Assessment Survey Jodie Elder, PharmD, BCPS September 14, 2017 Objectives List the key components of the Practice Advancement
More informationJoint Commission Update for Ambulatory Clinics
Joint Commission Update for Ambulatory Clinics Mary Beth McLellan, RN, BSN Manager of Clinical Operations Rapid City Regional Hospital Family Medicine Residency Program Objectives: Participants will understand
More informationUSP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD
USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL ACTIVITY DESCRIPTION On June 1, 2008, The Revision Bulletin to USP Chapter 797, Pharmaceutical
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationHospital Pharmacy Regulation Report
Vol. 2 No. 7 July 2004 Hospital Pharmacy Regulation Report INSIDE Drug card FAQ Check out some questions and answers pharmacists and patients should know about the Medicare-approved drug cards on pp. 5
More informationCNA Training Advisor
CNA Training Advisor Volume 14 Issue No. 9 SEPTEMBER 2016 As more attention is paid to quality of care, agencies need to focus on intangibles such as staff accountability and professionalism. All personnel,
More informationD DRUG DISTRIBUTION SYSTEMS
D DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Drug distribution systems in the hospital setting should ideally prevent medication errors from occurring. When errors do occur, the system
More informationJoint Commission quarterly update Medical record documentation guide and medical record reviews
April 2016 HIM Briefings Joint Commission quarterly update Medical record documentation guide and medical record reviews Jean S. Clark, RHIA, CSHA Our readers have been asking for an updated medical record
More informationPreventing Medical Errors
Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.
More informationObjective Competency Competency Measure To Do List
2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:
More informationPrescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationPharmaceutical Services Instructor s Guide CFR , (a)(b)(1) F425
Centers for Medicare & Medicaid Services (CMS) Pharmaceutical Services Instructor s Guide CFR 483.60, 483.60(a)(b)(1) F425 2006 Prepared by: American Institutes for Research 1000 Thomas Jefferson St, NW
More informationArizona Department of Health Services Licensing and CMS Deficient Practices
Arizona Department of Health Services Licensing and CMS Deficient Practices Connie Belden, RN., Bureau of Medical Facility Licensing August 8, 2013 General Comments Deficient Practices per visit Trend
More informationEmergency. Operations. Plan Template. Emergency. Preparedness Solutions. Chris Bellone, CEM, CHEP
Emergency Preparedness Solutions Emergency Operations Plan Template Chris Bellone, CEM, CHEP Emergency Preparedness Solutions: Emergency Operations Plan Template is published by HCPro, Inc. Copyright 2009
More informationA Discussion of Medication Error Reduction Strategies
A Discussion of Medication Error Reduction Strategies By: Donald L. Sullivan, R.Ph., Ph.D. Program Number: 071067-011-01-H05 C.E.U.s: 0.1 Contact Hours: 1 hour Release Date: 4/1/11 Expiration Date: 4/1/14
More informationThe Joint Commission Update: 2018
The Joint Commission Update: 2018 Target Audience: Pharmacists ACPE#: 0202-0000-18-007-L04-P Activity Type: Knowledge-based Target Audience: ACPE#: Activity Type: Disclosures Melinda C. Joyce declare(s)
More informationAccreditation Commission for Health Care
Questions Types of Accreditation Services Offered Does your organization have Medicare DMEPOS deemed status? (Yes/No) Is there an accreditation program for: (Yes/No) Yes Long Term Care (LTC) Pharmacy?
More informationMonitoring Medication Storage & Administration
Monitoring Medication Storage & Administration Objectives Review F-Tags pertaining to medication management Discuss proper medication storage and administration Understand medication cart and medication
More informationCNA Training Advisor
CNA Training Advisor Volume 14 Issue No. 4 APRIL 2016 Teamwork is the foundation for success in any healthcare system. Because teamwork allows individuals to combine their knowledge and skill sets to do
More informationCNA Training Advisor
CNA Training Advisor Volume 12 Issue No. 12 DECEMBER 2014 For healthcare workers, navigating ethical issues is a regular event. Unlike many professionals, caregivers don t offer quick fixes for saving
More informationElder abuse prevention
December 2010 Vol. 8, No. 12 Elder abuse and resident neglect are two of the most serious situations that can occur in a nursing home. All nursing home staff members, especially CNAs, need to be aware
More informationUnderstanding the Privacy and Security Regulations
Omnibus Rule Update HIPAA Handbook for Long-Term Care Staff Understanding the Privacy and Security Regulations Kate Borten, CISSP, CISM Handbook for Long-Term Care Staff Understanding the Privacy and Security
More informationSubmitted electronically via: May 20, 2015
Submitted electronically via: http://www.regulations.gov May 20, 2015 Jane Axelrad, JD Associate Director for Policy, CDER Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationAdvanced Nurse Practitioner Supervision Policy
Advanced Nurse Practitioner Supervision Policy Supervision requirements for nurse practitioners (NP) fall into two basic categories: Full practice and collaborative practice, which requires a Collaborative
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Medication Administration Observation
: Make random medication observations of several staff over different shifts and units, multiple routes of administration -- oral, enteral, intravenous (IV), intramuscular (IM), subcutaneous (SQ), topical,
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationLESSON ASSIGNMENT. Professional References in Pharmacy.
LESSON ASSIGNMENT LESSON 1 Professional References in Pharmacy. TEXT ASSIGNMENT Paragraphs 1-1 through 1-8. LESSON OBJECTIVES 1-1. Given a description of a reference used in pharmacy and a list of pharmacy
More informationProposed Standards Revisions Related to Pain Assessment and Management
Leadership (LD) Chapter LD.0001 Proposed Standards Revisions Related to Pain Assessment and Management 1 2 Leaders establish priorities for performance improvement. (Refer to the "Performance Improvement"
More information4/7/15. ASC Regulatory Update and Survey Trends. Objectives. Disclosure. Describe recent changes to the CMS interpretive guidelines.
ASC Regulatory Update and Survey Trends ASCRS/ASOA Symposium and Congress San Diego, CA April 2015 Regina Boore, RN, BSN, MS, CASC Objectives Describe recent changes to the CMS interpretive guidelines.
More informationHospital Pharmacy Regulation Report
Vol. 3 No. 2 February 2005 Hospital Pharmacy Regulation Report INSIDE Six CPOE tips Check out these tips to get physician acceptance of a CPOE system on p. 4. Make the call Find out how calling physicians
More informationJune 2018 Phc newsletter
June 2018 Phc newsletter News from CMS and Joint Commission Inside This Issue: ü Perspectives Leadership Session Be Prepared for Changes SAFER Matrix Placement Under Review - # RFIs Still Important Not
More informationMedication Administration & Preventing Errors M E A G A N R A Y, R N A M G S P E C I A L T Y H O S P I T A L
Medication Administration & Preventing Errors M E A G A N R A Y, R N A M G S P E C I A L T Y H O S P I T A L Principles of Medication Administration Talk with the patient and explain what you are doing
More informationNational Patient Safety Goals Effective January 1, 2016
National Patient Safety Goals Effective January 1, 2016 Goal 1 Improve the accuracy of patient identification. NPSG.01.01.01 Office-Based Surgery ccreditation Program Use at least two patient identifiers
More informationFundamentals of Medication Therapy Management (MTM) Services By Bruce R. Siecker, Ph.D., R.Ph.
Fundamentals of Medication Therapy Management (MTM) Services By Bruce R. Siecker, Ph.D., R.Ph. Bruce Siecker is president of Paradigm Research & Advisory Services, Inc. based in Stone Ridge, Virginia.
More informationAdvanced Sterile Product Preparation Training and Certificate Program
Advanced Sterile Product Preparation Training and Certificate Program ACPE Activity Number(s): 0204-0000-16-725-H04-P & T thru to 0204-0000-16-733-H04-P & T Release Date: November 7, 2016 Expiration Date:
More informationResearch Compliance Oversight in the Department of Veterans Affairs
Research Compliance Oversight in the Department of Veterans Affairs Karen M. Smith, PhD Director, Midwestern Regional Office Office of Research Oversight Department of Veterans Affairs Health Care Compliance
More informationNational Committee for Quality Assurance
National Committee for Quality Assurance (NCQA) Private, independent non-profit health care quality oversight organization founded in 1990 MISSION To improve the quality of health care. VISION To transform
More informationReducing the risk of serious medication errors in community pharmacy practice
Reducing the risk of serious medication errors in community pharmacy practice Eastern Medicaid Pharmacy Administrators Association (EMPAA) November 1, 2017 Newport, Rhode Island Michael R. Cohen, RPh,
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationHospital Pharmacy Regulation Report
Vol. 3 No. 12 December 2005 Hospital Pharmacy Regulation Report Book excerpt INSIDE Get eight expert tips on how to comply with the JCAHO s 2006 National Patient Safety Goal on medication labeling on p.
More informationPrepublication Requirements
Issued December 18, 2013 Prepublication Requirements The Joint ommission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the
More informationPHARMACY SERVICES / MEDICATION USE
25.01.02 Supervision of Pharmacy Activities. In order to provide patient safety, drugs and biologicals must be controlled and distributed in accordance with applicable standards of practice consistent
More informationPACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 7 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationCARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES
TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION 300.1610 MEDICATION POLICIES
More informationThe Journey to Meaningful Use: Where we were, where we are, and where we may be going
The Journey to Meaningful Use: Where we were, where we are, and where we may be going June 27, 2013 Matthew Stanford, WHA Louis Wenzlow, RWHC 1 Where have we been? When HIT Adop on Meaningful Use Adoption
More informationMEMORANDUM Texas Department of Human Services * Long Term Care/Policy
MEMORANDUM Texas Department of Human Services * Long Term Care/Policy TO: FROM: LTC-R Regional Directors Section/Unit Managers Marc Gold Section Manager Long Term Care Policy State Office MC: W-519 SUBJECT:
More informationExample of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)
Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia
More informationThe International Patient Safety Goals
The International Patient Safety Goals Updated for 6 th edition Hospital Standards The International Patient Safety Goals What are The International Patient Safety Goals (IPSG)? Required as of 1 st January
More informationCenter for Clinical Standards and Quality /Survey & Certification
TO DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Center for Clinical Standards and Quality /Survey
More informationEncouraging pharmacy involvement in pharmacovigilance; an international perspective.
Encouraging pharmacy involvement in pharmacovigilance; an international perspective. Michael R. Cohen, RPh, MS, ScD (hon) DPS (hon) Chairperson, International Medication Safety Network and President, Institute
More informationReport of the Task Force on Standardization of Technicians Role and Competencies
Report of the Task Force on Standardization of Technicians Role and Competencies Members Present: A. Jeffrey Newell (RI), chair; B. Belaire Bourg, Jr. (LA); Eugene P. Drake (AZ); Jeanne G. Furman (MD);
More informationStorage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431
Centers for Medicare & Medicaid Services (CMS) Storage, Labeling, Controlled Medications Instructor s Guide CFR 483.60(b)(2)(3)(d)(e) F431 2006 Prepared by: American Institutes for Research 1000 Thomas
More informationSafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting
SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2000 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical
More informationSTUDENT PERSONNEL MEDICATION POLICY ADMINISTRATIVE PROCEDURES
STUDENT PERSONNEL MEDICATION POLICY ADMINISTRATIVE PROCEDURES Procedures for Implementation of Medication Administration A. All administration of medication must be under the general supervision of a Licensed
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationMedicare & Medicaid EHR Incentive Programs Robert Tagalicod, Robert Anthony, and Jessica Kahn HIT Policy Committee January 10, 2012
Medicare & Medicaid EHR Incentive Programs Robert Tagalicod, Robert Anthony, and Jessica Kahn HIT Policy Committee January 10, 2012 Medica re Active Registrations December 2011 December-11 YTD Eligible
More informationVizient/AACN Nurse Residency Program TM. Jayne Willingham, MN, RN, CPHQ Senior Director Nursing Leadership
Vizient/AACN Nurse Residency Program TM Jayne Willingham, MN, RN, CPHQ Senior Director Nursing Leadership This is the new Vizient Country's largest health care performance improvement company Experts with
More informationCritical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital
Critical Access Hospitals Site Visit Summary 2014 2015 Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital 2014 2015 13 Critical Access Hospitals (CAH) Site Visits Compounded
More informationMedication Reconciliation
Medication Reconciliation The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart Technologies Today
More informationImmunizations Criminal Background check Infection Control HIPPA Health Insurance Portability and Accountability Act
Reedsburg Area Senior Life Center Welcome to Reedsburg Area Senior Life Center for your clinical! We hope you will have a positive and rewarding learning experience. If you have any questions during your
More informationMedication Reconciliation
Medication Reconciliation Define the term medication. Define medication reconciliation. Describe the potential barriers to obtaining an accurate medication list and resolution strategies to overcome these
More information2012 Medical Staff Update 2011 CHALLENGING STANDARDS/NPSGS
2012 Medical Staff Update Laurel McCourt, M.D. TJC Surveyor: Hospital and Office-Based Surgery Programs, and Special Survey Unit 2011 CHALLENGING STANDARDS/NPSGS 2 Standard/NPSG 2010 Non Compliance 3 2011
More information50 Essential Forms for Laboratory Compliance
Essential Forms for Laboratory Compliance With contributing editor Kelly A. Briganti, JD Achieve and demonstrate lab compliance with this book and CD-ROM set! Additional HCPro titles for your laboratory
More informationSite-Less CRO Model and esource: Framework for Action
Site-Less CRO Model and esource: Framework for Action Joe Martinez, RPh, PDE, PPC Princeton, NJ In-home and site-less clinical trials: changing the landscape How to test drugs, devices and procedures better
More informationPenticton & District Community Resources Society. Child Care & Support Services. Medication Control and Monitoring Handbook
Penticton & District Community Resources Society Child Care & Support Services Medication Control and Monitoring Handbook Revised Mar 2012 Table of Contents Table of Contents MEDICATION CONTROL AND MONITORING...
More informationContact Hours (CME version ONLY) Suggested Target Audience. all clinical and allied patient care staff. all clinical and allied patient care staff
1 Addressing Behaviors That Undermine a Culture of Safety PA CE CME FL 8/31/2016 2 2 7 3 43 1.0 1.0 1.0 all staff Sentinel Event Alert, Issue 40: Behaviors that undermine a culture of safety 2 Adverse
More informationCASE STUDY: PENINSULA REGIONAL MEDICAL CENTER
CASE STUDY: PENINSULA REGIONAL MEDICAL CENTER Incorporating IV room efficiencies while striving toward improving patient care 111852 2K 01/13 Page 1 of 5 OVERVIEW Peninsula Regional Medical Center (PRMC),
More information